Clinical Significance of microRNAs in Hematologic Malignancies and Hematopoietic Stem Cell Transplantation

Clinical Significance of microRNAs in Hematologic Malignancies and Hematopoietic Stem Cell Transplantation

Hematologic malignancies are a group of neoplastic conditions that can develop from any stage of the hematopoiesis cascade. Small non-coding microRNAs (miRNAs) play a crucial role in the post-transcriptional regulation of gene expression. Mounting evidence highlights the role of miRNAs in malignant...

Full description

Bibliographic Details
Main Authors:	Aneta Sevcikova, Ivana Fridrichova, Nataliia Nikolaieva, Lenka Kalinkova, Radoslav Omelka, Monika Martiniakova, Sona Ciernikova
Format:	Article
Language:	English
Published:	MDPI AG 2023-05-01
Series:	Cancers
Subjects:	microRNA hematologic malignancies malignant hematopoiesis hematopoietic stem cell transplantation graft-versus-host disease miRNA-based approach
Online Access:	https://www.mdpi.com/2072-6694/15/9/2658

Similar Items

Technical Advances in Single-Cell RNA Sequencing and Applications in Normal and Malignant Hematopoiesis
by: Xiang-tao Huang, et al.
Published: (2018-12-01)

Targeting DNA Methylation in Leukemia, Myelodysplastic Syndrome, and Lymphoma: A Potential Diagnostic, Prognostic, and Therapeutic Tool
by: Lenka Kalinkova, et al.
Published: (2022-12-01)

Gut Microbiota–MicroRNA Interactions in Intestinal Homeostasis and Cancer Development
by: Nataliia Nikolaieva, et al.
Published: (2022-12-01)

The miR-29 family in hematological malignancies
by: Barbora Fiserova, et al.
Published: (2015-06-01)

Epitranscriptomics in Normal and Malignant Hematopoiesis
by: Crescenzio Francesco Minervini, et al.
Published: (2020-09-01)

The Roles of Cholesterol and Its Metabolites in Normal and Malignant Hematopoiesis
by: Hideyuki Oguro
Published: (2019-04-01)

EPH/Ephrin Signaling in Normal Hematopoiesis and Hematologic Malignancies: Deciphering Their Intricate Role and Unraveling Possible New Therapeutic Targets
by: Ioanna E. Stergiou, et al.
Published: (2023-08-01)

Liquid biopsies for liquid tumors: emerging potential of circulating free nucleic acid evaluation for the management of hematologic malignancies
by: Jay Hocking, et al.
Published: (2016-06-01)

The role of histone acetyltransferases in normal and malignant hematopoiesis
by: Xiao-Jian eSun, et al.
Published: (2015-05-01)

Poly(rC)-binding proteins as pleiotropic regulators in hematopoiesis and hematological malignancy
by: Huijuan Zhao, et al.
Published: (2022-11-01)

Corrigendum: Poly(rC)-binding proteins as pleiotropic regulators in hematopoiesis and hematological malignancy
by: Huijuan Zhao, et al.
Published: (2023-02-01)

Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Hematological Malignancies
by: Mohammad Faizan Zahid, et al.
Published: (2014-12-01)

Should the BCRA1/2-mutations healthy carriers be valid candidates for hematopoietic stem cell donation?
by: Alberto Fresa, et al.
Published: (2021-04-01)

Pathogenic MicroRNA's in Myeloid Malignancies
by: Mona eKhalaj, et al.
Published: (2014-11-01)

The emerging field of opportunities for single-cell DNA methylation studies in hematology and beyond
by: Leone Albinati, et al.
Published: (2023-10-01)

Autophagy in Hematological Malignancies
by: Olga García Ruiz, et al.
Published: (2022-10-01)

miR-205-5p Downregulation and <i>ZEB1</i> Upregulation Characterize the Disseminated Tumor Cells in Patients with Invasive Ductal Breast Cancer
by: Lenka Kalinkova, et al.
Published: (2021-12-01)

Carbamazepine and Hematological Malignancies
by: İrfan Yavaşoğlu, et al.
Published: (2013-12-01)

Impact of natural killer cells on outcomes after allogeneic hematopoietic stem cell transplantation: A systematic review and meta-analysis
by: Muhammad Umair Mushtaq, et al.
Published: (2022-10-01)

The emerging landscape of exosomal CircRNAs in solid cancers and hematological malignancies
by: Qinfeng Zhou, et al.
Published: (2022-05-01)

Unveiling the complexity of transcription factor networks in hematopoietic stem cells: implications for cell therapy and hematological malignancies
by: Aissa Benyoucef, et al.
Published: (2023-06-01)

Patterns of Bone Marrow Confirmed Malignant and Non-Malignant Hematological Disorders in Patients with Abnormal Hematological Parameters in Northeast Ethiopia
by: Ebrahim H, et al.
Published: (2022-02-01)

Molecular Pathways in Clonal Hematopoiesis: From the Acquisition of Somatic Mutations to Transformation into Hematologic Neoplasm
by: Charles Gaulin, et al.
Published: (2022-07-01)

The clinicopathologic features of multiple primary malignancies in hematology: A cross sectional descriptive study
by: Pelin Aytan, et al.
Published: (2020-03-01)

Aging of Bone Marrow Mesenchymal Stromal Cells: Hematopoiesis Disturbances and Potential Role in the Development of Hematologic Cancers
by: Fulvio Massaro, et al.
Published: (2020-12-01)

Healthcare utilization and cost of cancer-related care prior to allogeneic hematopoietic cell transplantation for hematologic malignancies in the US: a retrospective real-world analysis
by: Machaon Bonafede, et al.
Published: (2021-10-01)

Effects of intensified conditioning on Epstein-Barr virus and cytomegalovirus infections in allogeneic hematopoietic stem cell transplantation for hematological malignancies
by: Xuan Li, et al.
Published: (2012-08-01)

Inflammasomes and the Maintenance of Hematopoietic Homeostasis: New Perspectives and Opportunities
by: Lijing Yang, et al.
Published: (2021-01-01)

Epidemiology of Invasive Fungal Diseases in Patients with Hematologic Malignancies and Hematopoietic Cell Transplantation Recipients Managed with an Antifungal Diagnostic Driven Approach
by: Maria Daniela Bergamasco, et al.
Published: (2021-07-01)

Single-cell RNA sequencing to track novel perspectives in HSC heterogeneity
by: Pan Zhang, et al.
Published: (2022-01-01)

Long-Term Dominance of Carbapenem-Non-Susceptible Pseudomonas aeruginosa ST111 in Hematologic Malignancy Patients and Hematopoietic Cell Transplant Recipients
by: Liyang Zhang, et al.
Published: (2022-06-01)

Insight into microRNAs’ involvement in hematopoiesis: current standing point of findings
by: Seyed Mahdi Nassiri, et al.
Published: (2023-10-01)

Efficacy and Safety of Doubly-Regulated Vaccinia Virus in a Mouse Xenograft Model of Multiple Myeloma
by: Muneyoshi Futami, et al.
Published: (2017-09-01)

Single-Cell Metabolomics in Hematopoiesis and Hematological Malignancies
by: Fengli Zuo, et al.
Published: (2022-07-01)

Roles of circRNAs in hematological malignancies
by: Fahua Deng, et al.
Published: (2022-07-01)

Cognitive impairments in patients with hematological malignancies prior and after allogeneic hematopoietic stem cells transplantation
by: D. E. Vybornykh, et al.
Published: (2019-07-01)

Infections in children and adolescents with hematological malignancies
by: Andishe Attarbaschi, et al.
Published: (2023-12-01)

Hematopoietic Stem Cell Niche During Homeostasis, Malignancy, and Bone Marrow Transplantation
by: Yan Man, et al.
Published: (2021-01-01)

Prognostic factors of second hematopoietic allogeneic stem cell transplantation among hematological malignancy patients relapsed after first hematopoietic stem cell transplantation: A single center study
by: Yue Lu, et al.
Published: (2023-01-01)

Challenges and Opportunities in Antimicrobial Stewardship among Hematopoietic Stem Cell Transplant and Oncology Patients
by: Anjali Majumdar, et al.
Published: (2023-03-01)